Blood and Cerebrospinal Fluid for Pediatric Brain Tumor Research
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01556178 |
Recruitment Status
:
Completed
First Posted
: March 16, 2012
Last Update Posted
: February 5, 2016
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Hydrocephalus |
Study Type : | Observational |
Actual Enrollment : | 5 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Official Title: | Collection of Blood and Cerebrospinal Fluid for Pediatric Brain Tumor Research |
Study Start Date : | July 2011 |
Actual Primary Completion Date : | April 2012 |
Actual Study Completion Date : | April 2012 |

Group/Cohort |
---|
Children without central nervous system tumors
Children without central nervous system tumors between the ages of 1 year and 21 years who are undergoing a neurosurgical procedure to address hydrocephalus
|
- levels of miRNAs in the blood and CSF [ Time Frame: 2 yrs ]
- Survivin and biologic markers levels in the CSF and blood [ Time Frame: 2 yrs ]
Biospecimen Retention: Samples Without DNA

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 1 Year to 21 Years (Child, Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Children without central nervous system tumors who are undergoing a neurosurgical procedure to address hydrocephalus during which CSF will be obtained
- Between the ages of 1 year and 21 years
- Patients must be having blood draws, lumbar punctures or CSF sampling from Ommaya reservoirs or VPS as part of routine clinical care.
Exclusion Criteria:
- Patients who do not require routine blood draws and/or CSF collection as part of their routine clinical care
- Patients who are considered too ill to participate as determined by their treating physician
- Patients with documented bacterial of viral infections of the CSF, brain parenchyma and/or neurosurgical devices and/or
- Patients with suspected de-myelinating conditions
- Patients who are pregnant or lactating.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01556178
United States, Illinois | |
Children's Memorial Hospital | |
Chicago, Illinois, United States, 60618 |
Principal Investigator: | Rishi Lulla, MD | Ann & Robert H Lurie Children's Hospital of Chicago |
Publications:
Responsible Party: | Rishi Lulla, Principal Investigator, Ann & Robert H Lurie Children's Hospital of Chicago |
ClinicalTrials.gov Identifier: | NCT01556178 History of Changes |
Other Study ID Numbers: |
2011-14612 |
First Posted: | March 16, 2012 Key Record Dates |
Last Update Posted: | February 5, 2016 |
Last Verified: | February 2016 |
Keywords provided by Rishi Lulla, Ann & Robert H Lurie Children's Hospital of Chicago:
Hydrocephalus Survivin miRNA |
Additional relevant MeSH terms:
Brain Neoplasms Hydrocephalus Central Nervous System Neoplasms Nervous System Neoplasms Neoplasms by Site |
Neoplasms Brain Diseases Central Nervous System Diseases Nervous System Diseases |